Evidence map›Paper›PMID 42287453›Full record

ReviewMammalian genome : official journal of the International Mammalian Genome Society2026

The evolution of AI-integrated genome editing and its challenges.

Matthew Tze Jian Wong, Nur Diyana Zulkifli, Thurgashini Ravichandran, Kalidasan Vasodavan, Osama Al-Shaibah, Galib Muhammad Shahriar Himel, Anusha Achuthan, Mohana Anita Anthonysamy, Kumitaa Theva Das

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mammalian genome : official journal of the International Mammalian Genome Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Matthew Tze Jian WongInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, Penang, Malaysia.
Nur Diyana ZulkifliInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, Penang, Malaysia.
Thurgashini RavichandranAdvanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia.
Kalidasan VasodavanInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, Penang, Malaysia.
Osama Al-ShaibahInstitute of Biological Sciences, Universiti Malaya, Kuala Lumpur, Malaysia.
Galib Muhammad Shahriar HimelSchool of Computer Sciences, Universiti Sains Malaysia, Penang, Malaysia.
Anusha AchuthanSchool of Computer Sciences, Universiti Sains Malaysia, Penang, Malaysia.
Mohana Anita AnthonysamyDepartment of Biosafety Malaysia, Putrajaya, Malaysia.
Kumitaa Theva DasInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, Penang, Malaysia. kumitaa@usm.my.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial Intelligence (AI) is poised to revolutionize the field of genome editing by enhancing precision, efficiency, and accessibility. AI-driven approaches are already improving the design of CRISPR-based systems by enabling more accurate identification of target sequences and predicting off-target effects. Machine learning (ML) algorithms can analyze vast genomic data, as well as identify patterns and mutations that might be overlooked by traditional methods. Taking together, utilizing AI/ML tools allow for the enhancement of every step in genome editing. Recent advances also demonstrated that AI-powered tools can facilitate the simulation and modeling of genetic modifications, predicting their effects on cellular behavior and phenotypes. This allows for a more rapid prediction of the genome editing effects, without the need for wet lab. Additionally, AI can accelerate drug discovery and therapeutic development by streamlining the identification of genetic targets and optimizing gene therapies. The integration of AI with genome editing promises to democratize access to cutting-edge technologies, enabling researchers to design and plan for complex genetic modifications with minimal technical expertise. Drawing from various examples, this paper dives into the advancements and applications of AI in genome editing, its limitations, as well as future directions and opportunities in this field.

Indexed as

Artificial IntelligenceGene EditingAnimalsCRISPR-Cas SystemsGenomicsHumansMachine Learning

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.